| [1] | Hailin CHENG, Xudong HU, Bing XIA, Tao BAI, Sixia LU. Clinical effect of tenofovir alafenamide fumarate on chronic hepatitis B patients with low viral load after entecavir treatment[J]. Journal of Clinical Hepatology, 2022, 38(3): 537-540. doi: 10.3969/j.issn.1001-5256.2022.03.009 |
| [2] | He CHEN, Juanjuan FU, Li LI, Guangde YANG, Xiucheng PAN. Influencing factors for low-level viremia in chronic hepatitis B patients treated with long-term entecavir antiviral therapy[J]. Journal of Clinical Hepatology, 2021, 37(3): 556-559. doi: 10.3969/j.issn.1001-5256.2021.03.011 |
| [3] | Shuqin LI, Jing ZHOU, Yuan GAO, Xiaoyan MA, Liping WANG. Antiviral effect of entecavir in chronic hepatitis B patients with rtA181V/T mutation[J]. Journal of Clinical Hepatology, 2021, 37(5): 1053-1058. doi: 10.3969/j.issn.1001-5256.2021.05.016 |
| [4] | Lin Jian, Fang XueQing, Song YouLiang. A case of recurrent liver dysfunction caused by NBAS gene mutation[J]. Journal of Clinical Hepatology, 2020, 36(9): 2069-2071. doi: 10.3969/j.issn.1001-5256.2020.09.034 |
| [5] | Hong ShengZhen, Xu Jie. Effect of entecavir versus tenofovir disoproxil fumarate antiviral therapy in reducing the risk of hepatocellular carcinoma in patients with chronic hepatitis B: Reflections on a Korean retrospective study[J]. Journal of Clinical Hepatology, 2019, 35(4): 734-736. doi: 10.3969/j.issn.1001-5256.2019.04.007 |
| [6] | Wang HaiXia, Qi Yue. Changes in serological markers of HBV during 4-year antiviral treatment with entecavir: A case report[J]. Journal of Clinical Hepatology, 2018, 34(12): 2648-2649. doi: 10.3969/j.issn.1001-5256.2018.12.027 |
| [7] | Wu YanQin, Shen LiJun, Yu JiHong, Sun YuShan. Clinical effect of entecavir in treatment of chronic hepatitis B complicated by hepatic steatosis[J]. Journal of Clinical Hepatology, 2017, 33(5): 849-852. doi: 10.3969/j.issn.1001-5256.2017.05.011 |
| [8] | An BaiQuan, Xin YongNing, Lu LinLin, Xuan ShiYing. Effect of PNPLA3 I148M mutation on expression of TGF- β1 in rat hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 769-771. doi: 10.3969/j.issn.1001-5256.2016.04.035 |
| [9] | Zhu DongLiang, Li DaoBo, Zhao ManZhi, Ma Ke, Song JianXin, Xu Dong. Clinical effect of entecavir in treatment of patients with chronic hepatitis B complicated by tuberculosis[J]. Journal of Clinical Hepatology, 2016, 32(11): 2084-2087. doi: 10.3969/j.issn.1001-5256.2016.11.014 |
| [10] | Xia ShuLin, He XiaoFeng. Efficacy of entecavir treatment for patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(4): 523-525. doi: 10.3969/j.issn.1001-5256.2015.04.011 |
| [11] | Wu LieXiu, Lin ShuMei, Zhang Xi, Zheng ShuQin, Ye Feng, Chen TianYan, Zhao YingRen, Zhang ShuLin. Dynamic changes in B7- H1 expression on peripheral blood mononuclear cells in chronic hepatitis B patients treated with entecavir[J]. Journal of Clinical Hepatology, 2014, 30(9): 929-931. doi: 10.3969/j.issn.1001-5256.2014.09.023 |
| [12] | Gao YuanZheng, Jia SuHua, Zhao LianFeng, Jiang Ying, Wang Yan. Clinical efficacy of entecavir combined with Xinganbao capsules in treatment of liver cirrhosis among patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(4): 314-316. doi: 10.3969/j.issn.1001-5256.2014.04.007 |
| [13] | Lei Man, He Song. Study of HBV- X gene mutation among patients with HBV- related chronic hepatitis, liver cirrhosis, and primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(6): 531-536. doi: 10.3969/j.issn.1001-5256.2014.06.013 |
| [14] | Zhang Wen, Yu JianGuo, Zhu GuiZhong, Zhao ZhanDong, Wang XiaoWei. Clinical efficacy of entecavir combined with adefovir in chronic hepatitis B patients with high viral load[J]. Journal of Clinical Hepatology, 2014, 30(11): 1169-1172. doi: 10.3969/j.issn.1001-5256.2014.11.019 |
| [15] | Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430. |
| [16] | Jin WenWen, Xin YongNing, Dong QuanJiang, Zhao ShouFeng, Yu XinJuan, Jiang Man, Xu Jing, Xuan ShiYing. The preliminary study on the relationship between hepatitis B virus BCP gene mutations and HBV-related primary hepatocellular carcinoma in Qingdao[J]. Journal of Clinical Hepatology, 2012, 28(2): 130-134. |
| [17] | Zheng JinXin, Yu Min, Xi HongLi, Zheng YingYing, Yin ShengJie, Zhang DuYi, Wang Fang, Ceng Zheng, Yu YanYan. The prevalence and significance of HBV basic core promoter /precore mutations in untreated chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2011, 27(3): 286-288. |
| [18] | Yang YaFang, Yang XiaoPing, Dong JianGuo, Wang ZhiGang, Liu YanPing, Zhao TieJun, Gao Feng. Analysis of short-term efficacy of entecavir and adefovir dipivoxil in the treatment of HBeAg-positive chronic hepatitis B [J]. Journal of Clinical Hepatology, 2010, 26(3): 326-327. |
| [19] | Luo LiSha, Zhang JiWan, Zhou JianLi, Kang Ning, He PengFei, Long Li, Zhang XiaoFang, Zhao ZhiYong, Wang HaiBin. Changes on the spots mutation of complement receptor type 1 and on erythrocytes immune adhesion function in HBeAg positive hepatitis patients[J]. Journal of Clinical Hepatology, 2010, 26(6): 635-637. |
| [20] | Yang GuiSheng, Wang HaiTao, Chang AiNa. Study of Entecavir in treating chronic hepatitis B Patients[J]. Journal of Clinical Hepatology, 2007, 23(6): 426-427. |
DownLoad: